Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits

Molecular Vision

Volumn 17, Issue , 2011, Pages 2056-2064

  Song, Zhengyu ^a   Gong, Yuanyuan ^a   Liu, Haiyun ^a   Ren, Qiushi ^b   Sun, Xiaodong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYRON; GLYCYRRHIZIC ACID; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; INTRAOCULAR HYPERTENSION; MALE; METABOLISM; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT;

ADMINISTRATION, ORAL; ANIMALS; AQUEOUS HUMOR; ELECTRORETINOGRAPHY; FOLLOW-UP STUDIES; GLAUCOMA; GLYCYRRHIZIC ACID; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OCULAR HYPERTENSION; PRINCIPAL COMPONENT ANALYSIS; RABBITS; RETINA; TONOMETRY, OCULAR; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 79961240139     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Jones R 3rd, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 2006; 17:163-167. [PMID: 16552251]
2. Ticho U, Lahav M, Berkowitz S, Yoffe P. Ocular changes in rabbits with corticosteroid-induced ocular hypertension. Br J Ophthalmol 1979; 63:646-650. [PMID: 158377]
3. Southren AL, Gordon GG, l'Hommedieu D, Ravikumar S, Dunn MW, Weinstein BI. 5 beta-Dihydrocortisol: possible mediator of the ocular hypertension in glaucoma. Invest Ophthalmol Vis Sci 1985; 26:393-395. [PMID: 3972522]
4. Weinstein BI, Munnangi P, Gordon GG, Southren AL. Defects in cortisol-metabolizing enzymes in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1985; 26:890-893. [PMID: 4008200]
5. Weinstein BI, Kandalaft N, Ritch R, Camras CB, Morris DJ, Latif SA, Vecsei P, Vittek J, Gordon GG, Southren AL. 5 alpha-dihydrocortisol in human aqueous humor and metabolism of cortisol by human lenses in vitro. Invest Ophthalmol Vis Sci 1991; 32:2130-2135. [PMID: 2055703]
6. Baath J, Ells AL, Crichton A, Kherani A, Williams RG. Safety profile of intravitreal triamcinolone acetonide. J Ocul Pharmacol Ther 2007; 23:304-310. [PMID: 17593015]
7. Jonas JB. Intravitreal triamcinolone acetonide for diabetic retinopathy. Dev Ophthalmol 2007; 39:96-110. [PMID: 17245081]
8. Roth DB, Verma V, Realini T, Prenner JL, Feuer WJ, Fechtner RD. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection. Ophthalmology 2009; 116:455-460. [PMID: 19157561]
9. Lau LI, Chen KC, Lee FL, Chen SJ, Ko YC, Liu CJ, Hsu WM. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection in a Chinese population. Am J Ophthalmol 2008; 146:573-578. [PMID: 18639860]
10. Candia OA, Gerometta R, Millar JC, Podos SM. Suppression of corticosteroid-induced ocular hypertension in sheep by anecortave. Arch Ophthalmol 2010; 128:338-343. [PMID: 20212205]
11. Spiga MG, Borrás T. Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma. Invest Ophthalmol Vis Sci 2010; 51:3029-3041. [PMID: 20089870]
12. Gerometta R, Spiga MG, Borrás T, Candia OA. Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus. Invest Ophthalmol Vis Sci 2010; 51:3042-3048. [PMID: 20089869]
13. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 1989; 264:18939-18943. [PMID: 2808402]
14. Kumagai K. Introduction of a new method for the preparation of triamcinolone acetonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2003; 23:881-882. [PMID: 14707849]
15. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004; 25:831-866. [PMID: 15466942]
16. Onyimba CU, Vijapurapu N, Curnow SJ, Khosla P, Stewart PM, Murray PI, Walker EA, Rauz S. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye. J Endocrinol 2006; 190:483-493. [PMID: 16899581]
17. Rauz S, Walker EA, Shackleton CHL, Hewison M, Murray PI, Stewart PM. Expression and putative role of 11β- hydroxysteroid dehydrogenase isozymes within the human eye. Invest Ophthalmol Vis Sci 2001; 42:2037-2042. [PMID: 11481269]
18. Rauz S, Cheung CM, Wood PJ, Coca-Prados M, Walker EA, Murray PI, Stewart PM. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. QJM 2003; 96:481-490. [PMID: 12881590]
19. Stewart PM, Krozowski ZS. 11 beta-Hydroxysterid dehydrogenase. Vitam Horm 1999; 57:249-324. [PMID: 10232052]
20. Morris DJ, Latif SA, Hardy MP, Brem AS. Endogenous inhibitors (GALFs) of 11β-hydroxysteroid dehydrogenase isoforms 1 and 2: Derivatives of adrenally produced corticosterone and cortisol. J Steroid Biochem Mol Biol 2007; 104:161-168. [PMID: 17459698]
21. Kim DH, Lee SW, Han MJ. Biotransformation of glycyrrhizin to l8-beta- glycyrrhetinic acid-3-O-beta-D-glucuronide by Streptceoeeus LJ-22, a human intestinal bacterium. Biol Pharm Bull 1999; 22:320-322. [PMID: 10220293]
22. Southren AL, Gordon GG, l'Hommedieu D, Ravikumar S, Dunn MW, Weinstein BI. 5 beta-Dihydrocortisol: possible mediator of the ocular hypertension in glaucoma. Invest Ophthalmol Vis Sci 1985; 26:393-395. [PMID: 3972522]
23. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29:1181-1189. [PMID: 10598751]
24. Fiehn O, Kopka J, Dörmann P, Altmann T, Trethewey RN, Willmitzer L. Metabolite profiling for plant functional genomics. Nat Biotechnol 2000; 18:1157-1161. [PMID: 11062433]
25. Lindon JC, Holmes E, Nicholson JK. Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn 2004; 4:189-199. [PMID: 14995905]
26. Robertson DG, Reily MD, Baker JD. Metabonomics in pharmaceutical discovery and development. J Proteome Res 2007; 6:526-539. [PMID: 17269709]
27. Bitter C, Suter K, Figueiredo V, Pruente C, Hatz K, Surber C. Preservative-free triamcinolone acetonide suspension developed for intravitreal injection. J Ocul Pharmacol Ther 2008; 24:62-69. [PMID: 18370876]
28. Song Z, Gao H, Liu H, Sun X. Metabolomics of Rabbit Aqueous Humor after Administration of Glucocorticosteroid. Curr Eye Res 2011; 36:563-570. [PMID: 21591866]
29. Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res 2008; 86:543-561. [PMID: 18313051]
30. Ashworth JL, Biswas S, Wraith E, Lloyd IC. Mucopolysaccharidoses and the eye. Surv Ophthalmol 2006; 51:1-17. [PMID: 16414358]
31. Löfberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, Bergström J, Alvestrand A. Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest 2002; 32:345-353. [PMID: 12027875]
32. Akiba S, Mukaida Y, Hane K, Oka M, Uozumi N, Shimizu T, Sato T. Group IVA phospholipase A2-mediated production of fibronectin by oxidized LDL in mesangial cells. Kidney Int 2006; 70:1013-1018. [PMID: 16837927]
33. Schurr A. Lactate, glucose and energy metabolism in the ischemic brain. Int J Mol Med 2002; 10:131-136. [PMID: 12119547]
34. Miller AM, Nolan MJ, Choi J, Koga T, Shen X, Yue BY, Knepper PA. Lactate treatment causes NF-kappa B activation and CD44 shedding in cultured trabecular meshwork cells. Invest Ophthalmol Vis Sci 2007; 48:1615-16121. [PMID: 17389491]
35. Parisi V, Manni G, Colacino G, Bucci MG. Cytidine-5′- diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology 1999; 106:1126-1134. [PMID: 10366081]
36. Parisi V. Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5′-diphosphocholine (citicoline): a study of 8 years of follow-up. Doc Ophthalmol 2005; 110:91-102. [PMID: 16249960]
37. Rejdak R, Toczołowski J, Kurkowski J, Kamiński ML, Rejdak K, Stelmasiak Z, Grieb P. Oral citicoline treatment improves visual pathway function in glaucoma. Med Sci Monit 2003; 9:PI24-PI28. [PMID: 12640353]
38. Grieb P, Rejdak R. Pharmacodynamics of citicoline relevant to the treatment of glaucoma. J Neurosci Res 2002; 67:143-148. [PMID: 11782957]
39. Virno M, Pecori-Giraldi J, Liguori A, De Gregorio F. The protective effect of citicoline on the progression of the perimetric defects in glaucomatous patients (perimetric study with a 10-year follow-up). Acta Ophthalmol Scand Suppl 2000; 78:56-57. [PMID: 11235540]
40. Chan KC, So KF, Wu EX. Proton magnetic resonance spectroscopy revealed choline reduction in the visual cortex in an experimental model of chronic glaucoma. Exp Eye Res 2009; 88:65-70. [PMID: 18992243]
41. Suzuki T, Sasano H, Kaneko C, Ogawa S, Darnel AD, Krozowski ZS. Immunohistochemical distribution of 11beta-hydroxysteroid dehydrogenase in human eye. Mol Cell Endocrinol 2001; 173:121-125. [PMID: 11223183]
42. Girard C, Eychenne B, Schweizer-Groyer G, Cadepond F. Mineralocorticoid and glucocorticoid receptors in sciatic nerve function and regeneration. J Steroid Biochem Mol Biol 2010; 122:149-158. [PMID: 20678573]